2,249
Views
56
CrossRef citations to date
0
Altmetric
Reviews

Pulmonary effects of inhaled cannabis smoke

ORCID Icon & ORCID Icon
Pages 596-609 | Received 15 Feb 2019, Accepted 31 May 2019, Published online: 12 Jul 2019

References

  • Schulenberg JE, Johnston LD, O’Malley PM, Bachman JG, Miech RA, Patrick ME. Monitoring the future national survey results on drug use, 1975–2017: volume II, College students and adults ages 19–55. Ann Arbor: Institute for Social Research, The University of Michigan, 2018. Retrieved from http://monitoringthefuture.org/pubs.html#monographs.
  • Chen JC, Green KM, Arria AM, Borzekowski DLG. Prospective predictors of flavored e-cigarette use: A one-year longitudinal study of young adults in the. U.S. Drug Alcohol Depend. 2018;191:279–85. doi:10.1016/j.drugalcdep.2018.07.020.
  • Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol. 1999;20:1286–93. doi:10.1165/ajrcmb.20.6.3424.
  • Sarafian TA, Kouyoumjian S, Khoshaghideh F, Tashkin DP, Roth MD. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol Lung Cell Mol Physiol. 2003;284:L298–L306. doi:10.1152/ajplung.00157.2002.
  • Singh N, Hroudová J, Fišar Z. Cannabinoid-induced changes in the activity of electron transport chain complexes of brain mitochondria. J Mol Neurosci. 2015;56:926–31. doi:10.1007/s12031-015-0545-2.
  • Hernández-Tiedra S, Fabriàs G, Dávila D, Salanueva ÍJ, Casas J, Montes LR, Antón Z, García-Taboada E, Salazar-Roa M, Lorente M, et al. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016;12:2213–29. doi:10.1080/15548627.2016.1213927.
  • Maertens RM, White PA, Williams A, Yauk CL. A global toxicogenomic analysis investigating the mechanistic differences between tobacco and marijuana smoke condensates in vitro. Toxicology. 2013;308:60–73. doi:10.1016/j.tox.2013.03.008.
  • van Niekerk G, Mabin T, Engelbrecht AM. Anti-inflammatory mechanisms of cannabinoids: an immunometabolic perspective. Inflammopharmacology 2019; Advance online publication. doi:10.1007/s10787-018-00560-7
  • Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1:1333–49. doi:10.4155/fmc.09.93.
  • Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD. Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol. 2002;133:124–31.
  • Roth MD, Castaneda JT, Kiertscher SM. Exposure to Δ9-tetrahydrocannabinol impairs the differentiation of human monocyte-derived dendritic cells and their capacity for T cell activation. J Neuroimmune Pharmacol. 2015;10:333–43. doi:10.1007/s11481-015-9587-z.
  • Hoffmann D, Brunnemann KD, Gori GB, Wynder EL. On the carcinogenicity of marijuana smoke. In: Runeckles VC, editor. Recent advances in phytochemistry. Boston, MA: Springer; 1975. p. 63–81.
  • Novotný M, Merli F, Wiesler D, Fenci M, Saeed T. Fractionation and capillary gas chromatographic-mass spectrometric characterization of the neutral components in marijuana and tobacco smoke condensates. J Chromatogr. 1982;238:141–50. doi:10.1016/S0021-9673(00)82720-X.
  • Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, White P, Desjardins S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2007;21:494–502. doi:10.1021/tx700275p.
  • Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol. 2001;24:339–44. PMID: 11245634. doi:10.1165/ajrcmb.24.3.4252.
  • Moorthy B, Chu C, Carlin DJ. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci. 2015;145:5–15. doi:10.1093/toxsci/kfv040.
  • Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347–51. doi:10.1056/NEJM198802113180603.
  • Tashkin DP, Gliederer F, Rose J, Change P, Hui KK, Yu JL, Wu TC. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC. Pharmacol Biochem Behav. 1991;40:651–56.
  • Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. Br Med J. 1987;295:1516–18. doi:10.1136/bmj.295.6612.1516.
  • Tashkin DP, Coulson AH, Clark VA, Simmons M, Bourque LB, Duann S, Spivey GH, Gong H. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987;135:209–16. doi:10.1164/arrd.1987.135.1.209.
  • Sherrill DL, Krzyzanowski M, Bloom JW, Lebowitz MD. Respiratory effects of non-tobacco cigarettes: A longitudinal study in general population. Int J Epidemiol. 1991;20:132–37. doi:10.1093/ije/20.1.132.
  • Taylor DR, Poulton R, Moffit TE, Ramankutty P, Sears M. The respiratory effects of cannabis dependence in young adults. Addiction. 2000;95:1669–77.
  • Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med. 2004;20:33–37. doi:10.1111/j.1525-1497.2004.40081.x.
  • Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62:1058–63. doi:10.1136/thx.2006.077081.
  • Tan WC, Lo C, Jong A, Xing L, Fitzgerald MJ, Vollmer WM, Buist SA, Sin DD; Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group. Marijuana and chronic obstructive lung disease - a population-based study. Cmaj. 2009;180:814–20.
  • Macleod J, Robertson R, Copeland L, McKenzie J, Elton R, Reid P. Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population. Br J Gen Pract. 2015;65:e89–e95. doi:10.3399/bjgp15X683521.
  • Hancox RJ, Shin HH, Gray AR, Poulton R, Sears M. Effects of quitting cannabis on respiratory symptoms. Eur Respir J. 2015;46:80–87. doi:10.1183/09031936.00228914.
  • McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, Samet J, Leventhal A, Berhane K. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195:1043–49. doi:10.1164/rccm.201604-0804OC.
  • Nadel JA, Comroe JH Jr. Acute effects of inhalation of cigarette smoke on airway conductance. J Appl Physiol. 1961;16:713–16. doi:10.1152/jappl.1961.16.4.713.
  • Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral ∆9-tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289:336–34l. doi:10.1056/NEJM197308162890702.
  • Tashkin DP, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral ∆9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis. 1974;l09:420–28.
  • Tashkin DP, Shapiro BJ, Lee EY, Harper CE. Effects of smoked marijuana in experimentally induced asthma. Am Rev Respir Dis. 1975;112:377–86. doi:10.1164/arrd.1975.112.3.377.
  • Vachon L, FitzGerald MX, Solliday NH, Gould IA, Gaensler EA. Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med. 1973;288:985–89. doi:10.1056/NEJM197305102881902.
  • Williams SJ, Hartley JP, Graham JD. Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax. 1976;31:720–23. doi:10.1136/thx.31.6.720.
  • Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature. 2000;408:96–101. doi:10.1038/35040576.
  • Grassin‐Delyle S, Naline E, Buenestado A, Faisy C, Alvarez JC, Salvator H, Abrial C, Zemoura L, Devillier P. Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors. Br J Pharmacol. 2014;171:2767–77. doi:10.1111/bph.12597.
  • Grinspoon L. Marijuana. Sci Am. 1969;221:17–25.
  • Tashkin DP, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respir Dis. 1977;115:57–65. doi:10.1164/arrd.1977.115.1.57.
  • Abdallah SJ, Smith BM, Ware MA, Moore M, Li PZ, Bourbeau J, Jensen D. Effect of vaporized cannabis on exertional breathlessness and exercise endurance in advanced chronic obstructive pulmonary disease. A randomized controlled trial. Ann Am Thorac Soc. 2018;15:1146–58. doi:10.1513/AnnalsATS.201803-198OC.
  • Tashkin DP, Calvarese BM, Simmons MS, Shapiro B. Respiratory status of seventy-four habitual marijuana smokers. Chest. 1980;78:699–706. doi:10.1378/chest.78.5.699.
  • Hancox RJ, Poulton R, Ely M, Welch D, Taylor DR, McLachlan CR, Greene JM, Moffitt TE, Caspi A, Sears MR. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35:42–47. doi:10.1183/09031936.00065009.
  • Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on respiratory health in U.S. adults. Ann Am Thorac Soc. 2015;12:135–41. doi:10.1513/AnnalsATS.201407-333OC.
  • Morris MA, Jacobson SR, Kinney GL, Tashkin DP, Woodruff PG, Hoffman EA, Kanner RE, Cooper CB, Drummond MB, Barr RG, et al. Cannabis use associations with pulmonary symptoms and function in the subpopulation and intermediate outcome measures in COPD study. Chronic Obstr Pulm Dis. 2018;5:46–56. doi:10.15326/jcopdf.5.1.2017.0141.
  • Tan WC, Bourbeau J, Maltais F, Hernandez P, Marciniuk D, O’Donnell D, Walker BL, Chapman KR, Fitzgerald JM, Road J, et al. Marijuana smoking in the middle-aged and elderly population is associated with rapid decline in FEV1. Am J Respir Crit Care Med. 2018;197:A4450.
  • Tashkin DP, Simmons MS, Sherrill D, Coulson AH. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am J Respir Crit Care Med. 1997;155:141–48. doi:10.1164/ajrccm.155.1.9001303.
  • Bhatt S, Kim Y-L, Harrington KF, Hokanson JE, Lutz S, Cho MH, DeMeo DL, Wells JM, Make BJ, Rennard SI, et al.; COPDGene Investigators. Smoking duration alone predicts emphysema and lung function better than pack years. Thorax. 2018;73:414–21.
  • Herth FJF, Kirby M, Sieren J, Herth J, Schirm J, Wood S, Schuhmann M. The modern art of reading computed tomography images of the lungs: quantitative CT. Respiration. 2018;95:8–17. doi:10.1159/000480435.
  • Thompson AB, Huerta G, Robbins RA, Sisson JH, Spurzem JR, von Essen S, Rickard KA, Romberger DJ, Rubinstein I, Ghafouri M, et al. The bronchitis index. A semiquantitative visual scale for the assessment of airways inflammation. Chest. 1993;103:1482–88. doi:10.1378/chest.103.5.1482.
  • Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med. 1998;157:928–37. doi:10.1164/ajrccm.157.3.9701026.
  • Barbers RG, Gong H Jr, Tashkin DP, Oishi J, Wallace JM. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am Rev Respir Dis. 1987;135:1271–127.
  • Fligiel SE, Venkat H, Gong H Jr, Tashkin DP. Bronchial pathology in chronic marijuana smokers: a light and electron microscopic study. J Psychoactive Drugs. 1988;20:33–42. doi:10.1080/02791072.1988.10524369.
  • Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112:319–26. doi:10.1378/chest.112.2.319.
  • Bailey KL, Wyatt TA, Katafiasz DM, Taylor KW, Heires AJ, Sisson JH, Romberger DJ, Burnham EL. Alcohol and cannabis use alter pulmonary innate immunity. Alcohol 2018; Advance online publication. doi:10.1016/j.alcohol.2018.11.002
  • Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine and/or tobacco. J Natl Cancer Inst. 1998;90:1198–200. doi:10.1093/jnci/90.16.1198.
  • Castaneda JT, Harui A, Kiertscher SM, Roth JD, Roth MD. Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes. J Neuroimmune Pharmacol. 2013;8:323–32. doi:10.1007/s11481-012-9430-8.
  • Baldwin GC, Tashkin DP, Buckley DM, Park AN, Dubinett SM, Roth MD. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med. 1997;156:1606–13. doi:10.1164/ajrccm.156.5.9704146.
  • Roth MD, Whittaker K, Salehi K, Tashkin DP, Baldwin GC. Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J Neuroimmunol. 2004;147:82–86.
  • Shay AH, Choi R, Whittaker K, Salehi K, Kitchen CMR, Tashkin DP, Roth MD, Baldlwin GC. Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokes of marijuana and cocaine. J Infect Dis. 2003;187:700–04. doi:10.1086/368370.
  • Tan WC, Sin DD. What are the long-term effects of smoked marijuana on lung health? Cmaj. 2018;190:E1243–E1244. doi:10.1503/cmaj.181307.
  • Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, Dubinett SM. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000;165:373–80. doi:10.4049/jimmunol.165.1.373.
  • Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and its relation to lung cancer. N Engl J Med. 1961;265:253–67. doi:10.1056/NEJM196108102650601.
  • Bhattacharya S, Mandal S, Banerjee S, Mandal GK, Bhowmick AK, Murmu N. Cannabis smoke can be a major risk factor for early-age laryngeal cancer - a molecular signaling-based approach. Tumor Biol. 2015;36:6029–36. doi:10.1007/s13277-015-3279-4.
  • Taylor FM. Marijuana as a potential respiratory tract carcinogen: A retrospective analysis of a community hospital population. South Med J. 1988;81:1213–16.
  • Donald PJ. Advanced malignancy in the young marijuana smoker. In: Friedman H, Specter S, Klein TW, (editors) Drugs of abuse, immunity, and immunodeficiency. Advances in Experimental Medicine and Biology. (Vol. 288, pp. 33–46). Boston, MA: Springer; 1991.
  • Sridhar KS, Raub WA, Weatherby NL, Metsch LR, Surratt HL, Inciardi JA, Duncan RC, Anwyl RS, McCoy CB. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs. 1994;26:1285–88. doi:10.1080/02791072.1994.10472442.
  • Endicott JN, Skipper P, Hernandez L. Marijuana and head and neck cancer. In: Friedman H, Klein TW, Specter S, (editors) Drugs of abuse, immunity, and AIDS. Advances in Experimental Medicine and Biology. (Vol. 335, pp. 107–13). Boston, MA: Springer; 1993.
  • Fung M, Gallagher C, Machtay M. Lung and aero-digestive cancers in young marijuana smokers. Tumori. 1999;85:140–42.
  • Hsairi M, Achour N, Zouari B, Ben RH, Achour A, Maalej M, Nacef T. Etiologic factors in primary bronchial carcinoma in Tunisia. Tunis Med. 1993;71:265–68.
  • Sasco AJ, Merrill RM, Dari I, Benhaïm-Luzon V, Carriot F, Cann CI, Bartal M. A case–control study of lung cancer in Casablanca, Morocco. Cancer Causes Control. 2002;13:609–16.
  • Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R. Cannabis use and risk of lung cancer: a case–control study. Eur Respir J. 2008;31:280–86. doi:10.1183/09031936.00065707.
  • Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013;24:1811–20. doi:10.1007/s10552-013-0259-0.
  • Hinz B, Ramer R. Anti-tumour actions of cannabinoids. Br J Pharmacol 2018; Advance online publication. doi:10.1111/bph.14426
  • Velasco G, Sanchez C, Guzman M. Towards the use of cannabinoids as anti-tumour agents. Nat Rev Cancer. 2012;12:436–44. doi:10.1038/nrc3247.
  • Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997;8:722–28.
  • Zhang LR, Morgenstern H, Greenland S, Chang S-C, Lazarus P, Dawn Teare M, Wolf PJ, Orlow I, Cox B. Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015;136:894–903. doi:10.1002/ijc.29036.
  • Tashkin DP. Marijuana and Lung Disease. Chest. 2018 Sep;154:653–63. doi:10.1016/j.chest.2018.05.005.
  • Kagen SL, Kurup VP, Sohnle PC, Fink J. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol. 1983;71:389–93.
  • Ungerleider JT, Andrysiak T, Tashkin DP, Gale RP. Contamination of marihuana cigarettes with pathogenic bacteria – possible source of infection in cancer patients. Cancer Treat Rep. 1982;66:589–91.
  • Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:654–62. doi:10.1056/NEJM199103073241003.
  • Chusid MJ, Gelfiand JA, Nutter C, Fauci AS. Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease. Ann Intern Med. 1975;82:682–83.
  • Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana in a marrow transplant recipient. Chest. 1988;94:432–33. doi:10.1378/chest.94.2.432.
  • Marks WH, Florence L, Lieberman J, Chapman P, Howard D, Roberts P, Perkinson D. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation. 1996;61:1771–83.
  • Sutton S, Lum BL, Torti FM. Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer. Drug Intell Clin Pharm. 1986;20:289–91. doi:10.1177/106002808602000416.
  • Newell GR, Mansel PW, Wilson MB, Lynch HK, Spitz MR, Hersh EM. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev Med. 1985;14:81–91.
  • Tindall B, Cooper DA, Gold J, Donovan B, Barnes T, Philpot CR, Gold J, Penny R. The Sydney AIDS project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Aust N Z J Med. 1988;18:8–15.
  • Caiaffa WT, Vlahov D, Graham NMH, Astemborski J, Solomon L, Nelson KE, Munoz A. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppresion increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive infection drug users. Am J Respir Crit Care Med. 1994;150:1493–98. doi:10.1164/ajrccm.150.6.7952605.
  • Kaslow RA, Blackwelder WC, Ostrow DG, Yerg D, Palenicek J, Coulson AH, Valdiserri RO. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals: A report from the Multicenter AIDS Cohort Study. JAMA. 1989;261:3424–29.
  • Lorenz DR, Uno H, Wolinsky SM, Gabuzda D. Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: A longitudinal cohort study. EClinical Medicine. 2019;7:(Jan):55–64. doi:10.1016/j.eclinm.2019.01.003.
  • Tashkin DP, Quint J, Detels R. Marijuana smoking and pneumonia risk: findings from the Multi-Center AIDS Cohort Study. Am J Respir Crit Care Med. 2018;197:A6097.
  • Mattox KL. Pneumomediastinum in heroin and marijuana users. Jacep. 1976;5:26–28.
  • Birrer RB, Calderon J. Pneumothorax, pneumomediastinum, and pneumopericardium following Valsalva’s maneuver during marijuana smoking. N Y State J Med. 1984;84:619–20.
  • Luque III MA, Cavallaro DL, Torres M, Emmanuel P, Hillman JV. Pneumomediastinum, pneumothorax, and subcutaneous emphysema after alternate cocaine inhalation and marijuana smoking. Pediatr Emerg Care. 1987;3:107–1097.
  • Herrejón SA, Blanquer OJ, Simo MM, Ruiz Montalt F, Nunez Sanchez C, Vives C. Pneumothorax due to drug inhalation. An Med Interna (Madrid, Spain). 1984;9:137–39.
  • Feldman AL, Sullivan JT, Passero MA, Lewis DC. Pneumothorax in polysubstance-abusing marijuana and tobacco smokers: three cases. J Subst Abuse. 1993;5:183–86.
  • Hazouard E, Koninck JC, Attucci S, Fauchier-Rolland F, Brunereau L, Diot P. Pneumorachis and pneumomediastinum caused by repeated Müller’s maneuvers: complications of marijuana smoking. Ann Emerg Med. 2001;38:694–97. doi:10.1067/mem.2001.118016.
  • Goodyear K, Laws D, Turner J. Bilateral spontaneous pneumothorax in a cannabis smoker. J R Soc Med. 2004;97:435–36. doi:10.1258/jrsm.97.9.435.
  • Beshay M, Kaiser H, Niedhart D, Reymond MA, Schmid RA. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg. 2007;32:834–38. doi:10.1016/j.ejcts.2007.07.039.
  • Johnson MK, Smith RP, Morrison D, Lascio G, White RJ. Large lung bullae in marijuana smokers. Thorax. 2000;55:340–42. doi:10.1136/thorax.55.4.340.
  • Thompson CS, White RJ. Lung bullae and marijuana. Thorax. 2002;57:563. doi:10.1136/thorax.57.6.563.
  • Phan TD, Lau KK, Li X. Lung bullae and pulmonary fibrosis associated with marijuana smoking. Australas Radiol. 2005;49:411–14. doi:10.1111/j.1440-1673.2005.01472.x.
  • Hii SW, Tam JD, Thompson BR, Naughton MT. Bullous lung disease due to marijuana. Respirology. 2008;13:122–27. doi:10.1111/j.1440-1843.2007.01186.x.
  • Tan C, Hatam N, Treasure T. Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link. J R Soc Med. 2006;99:77–80. doi:10.1258/jrsm.99.2.77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.